Article
Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
Bone - 1 Jul 2014
Atay Zeynep, Bereket Abdullah, Haliloglu Belma, Abali Saygin, Ozdogan Tutku, Altuncu Emel, Canaff Lucie, Vilaça Tatiane, Wong Betty Y L, Cole David E C, Hendy Geoffrey N, Turan Serap
Abstract excerpt
BACKGROUND: NSHPT is a life-threatening disorder caused by homozygous inactivating calcium-sensing receptor (CASR) mutations. In some cases, the CaSR allosteric activator, cinacalcet, may reduce serum PTH and calcium levels, but surgery is the treatment of choice. OBJECTIVE: To describe a case of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
